1. Review the role of genomic testing in ER+ breast cancer.

2. Review data from TAILORx trial. 

3. Review additional relevant ASCO presentations.

GastrointestinalProvide updates to evidence-based management options. 


1. To review outcomesin recurrent uterine and ovarian cancer with both traditional chemotherapy and targeted agents. 

2. To review most recent data on chemotherapy in rare gynecologic tumors. 

Session date: 
Thursday, September 13, 2018 - 8:00am to 9:00am
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Drs. Poornima Saha, Mary Jenkins Vogel & Marisa Hill